Dynamic regulation of Gata1 expression during the maturation of conventional dendritic cells

Experimental Hematology

Volumn 38, Issue 6, 2010, Pages

  Kozma, Gergely T ^a   Martelli, Fabrizio ^a   Verrucci, Maria ^a   Gutiérrez, Laura ^b   Migliaccio, Giovanni ^a   Sanchez, Massimo ^a   Alfani, Elena ^a   Philipsen, Sjaak ^b   Migliaccio, Anna Rita ^a,c  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GREEN FLUORESCENT PROTEIN; HISTONE H4; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; TRANSCRIPTION FACTOR GATA 1;

ACETYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; BONE MARROW CELL; CELL COUNT; CELL MATURATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DENDRITIC CELL; EX VIVO STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE FUNCTION; GENE MUTATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR OCCUPANCY; REGULATORY SEQUENCE; REPORTER GENE; SEQUENCE ANALYSIS; STEM CELL; WILD TYPE;

MUS;

EID: 77952906744     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2010.03.006     Document Type: Article

References (55)

1. Watts C. Capture and processing of exogenous antigens for presentation on MHC molecules. Annu Rev Immunol 1997, 15:821-850.
2. Shortman K., Liu Y.J. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2002, 2:151-161.
3. Grouard G., Rissoan M.C., Filgueira L., Durand I., Banchereau J., Liu Y.J. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med 1997, 185:1101-1111.
4. Theofilopoulos A.N., Baccala R., Beutler B., Kono D.H. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 2005, 23:307-336.
5. Asselin-Paturel C., Boonstra A., Dalod M., et al. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat Immunol 2001, 2:1144-1150.
6. Inaba K., Inaba M., Deguchi M., et al. Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow. Proc Natl Acad Sci U S A 1993, 90:3038-3042.
7. Wu L., Liu Y.J. Development of dendritic-cell lineages. Immunity 2007, 26:741-750.
8. Cella M., Engering A., Pinet V., Pieters J., Lanzavecchia A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 1997, 388:782-787.
9. Maldonado-Lopez R., De Smedt T., Michel P., et al. CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J Exp Med 1999, 189:587-592.
10. Mason D.W., Pugh C.W., Webb M. The rat mixed lymphocyte reaction: roles of a dendritic cell in intestinal lymph and T-cell subsets defined by monoclonal antibodies. Immunology 1981, 44:75-87.
11. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994, 179:1109-1118.
12. Sallusto F., Cella M., Danieli C., Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995, 182:389-400.
13. Randolph G.J., Angeli V., Swartz M.A. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat Rev Immunol 2005, 5:617-628.
14. Kroczek R.A., Mages H.W., Hutloff A. Emerging paradigms of T-cell co-stimulation. Curr Opin Immunol 2004, 16:321-327.
15. Riley J.L., Mao M., Kobayashi S., et al. Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors. Proc Natl Acad Sci U S A 2002, 99:11790-11795.
16. Witsch E.J., Peiser M., Hutloff A., et al. ICOS and CD28 reversely regulate IL-10 on re-activation of human effector T cells with mature dendritic cells. Eur J Immunol 2002, 32:2680-2686.
17. Tureci O., Bian H., Nestle F.O., et al. Cascades of transcriptional induction during dendritic cell maturation revealed by genome-wide expression analysis. FASEB J 2003, 17:836-847.
18. Fujii S., Liu K., Smith C., Bonito A.J., Steinman R.M. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J Exp Med 2004, 199:1607-1618.
19. Cantor A.B., Orkin S.H. Transcriptional regulation of erythropoiesis: an affair involving multiple partners. Oncogene 2002, 21:3368-3376.
20. Gutierrez L., Nikolic T., van Dijk T.B., et al. Gata1 regulates dendritic-cell development and survival. Blood 2007, 110:1933-1941.
21. Tanaka H., Matsumura I., Nakajima K., et al. GATA-1 blocks IL-6-induced macrophage differentiation and apoptosis through the sustained expression of cyclin D1 and bcl-2 in a murine myeloid cell line M1. Blood 2000, 95:1264-1273.
22. Bakri Y., Sarrazin S., Mayer U.P., et al. Balance of MafB and PU.1 specifies alternative macrophage or dendritic cell fate. Blood 2005, 105:2707-2716.
23. Arinobu Y., Mizuno S., Chong Y., et al. Reciprocal activation of GATA-1 and PU.1 marks initial specification of hematopoietic stem cells into myeloerythroid and myelolymphoid lineages. Cell Stem Cell 2007, 1:416-427.
24. Chen J.Y., You Y.K., Chen J.C., Huang T.C., Kuo C.M. Organization and promoter analysis of the zebrafish (Danio rerio) interferon gene. DNA Cell Biol 2005, 24:641-650.
25. Sundrud M.S., Vancompernolle S.E., Eger K.A., et al. Transcription factor GATA-1 potently represses the expression of the HIV-1 coreceptor CCR5 in human T cells and dendritic cells. Blood 2005, 106:3440-3448.
26. Triantis V., Moulin V., Looman M.W., Hartgers F.C., Janssen R.A., Adema G.J. Molecular characterization of the murine homologue of the DC-derived protein DC-SCRIPT. J Leukoc Biol 2006, 79:1083-1091.
27. McKimmie C.S., Fraser A.R., Hansell C., et al. Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1. J Immunol 2008, 181:8171-8181.
28. Göbel F., Taschner S., Jurkin J., et al. Reciprocal role of GATA-1 and vitamin D receptor in human myeloid dendritic cell differentiation. Blood 2009, 114:3813-3821.
29. McDevitt M.A., Shivdasani R.A., Fujiwara Y., Yang H., Orkin S.H. A " knockdown" mutation created by cis-element gene targeting reveals the dependence of erythroid cell maturation on the level of transcription factor GATA-1. Proc Natl Acad Sci U S A 1997, 94:6781-6785.
30. Takahashi S., Onodera K., Motohashi H., et al. Arrest in primitive erythroid cell development caused by promoter-specific disruption of the GATA-1 gene. J Biol Chem 1997, 272:12611-12615.
31. Onodera K., Takahashi S., Nishimura S., et al. GATA-1 transcription is controlled by distinct regulatory mechanisms during primitive and definitive erythropoiesis. Proc Natl Acad Sci U S A 1997, 94:4487-4492.
32. Takahashi S., Shimizu R., Suwabe N., et al. GATA factor transgenes under GATA-1 locus control rescue germline GATA-1 mutant deficiencies. Blood 2000, 96:910-916.
33. Yu C., Cantor A.B., Yang H., et al. Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo. J Exp Med 2002, 195:1387-1395.
34. Shimizu R., Kuroha T., Ohneda O., et al. Leukemogenesis caused by incapacitated GATA-1 function. Mol Cell Biol 2004, 24:10814-10825.
35. Pan X., Ohneda O., Ohneda K., et al. Graded levels of GATA-1 expression modulate survival, proliferation, and differentiation of erythroid progenitors. J Biol Chem 2005, 280:22385-22394.
36. Ito E., Toki T., Ishihara H., et al. Erythroid transcription factor GATA-1 is abundantly transcribed in mouse testis. Nature 1993, 362:466-468.
37. Nishimura S., Takahashi S., Kuroha T., et al. A GATA box in the GATA-1 gene hematopoietic enhancer is a critical element in the network of GATA factors and sites that regulate this gene. Cell Biol 2000, 20:713-723.
38. Vyas P., Ault K., Jackson C.W., Orkin S.H., Shivdasani R.A. Consequences of GATA-1 deficiency in megakaryocytes and platelets. Blood 1999, 93:2867-2875.
39. Vyas P., McDevitt M.A., Cantor A.B., Katz S.G., Fujiwara Y., Orkin S.H. Different sequence requirements for expression in erythroid and megakaryocytic cells within a regulatory element upstream of the GATA-1 gene. Development 1999, 126:2799-2811.
40. Migliaccio A.R., Rana R.A., Sanchez M., et al. GATA-1 as a regulator of mast cell differentiation revealed by the phenotype of the GATA-1low mouse mutant. J Exp Med 2003, 197:281-296.
41. Hirasawa R., Shimizu R., Takahashi S., et al. Essential and instructive roles of GATA factors in eosinophil development. J Exp Med 2002, 195:1379-1386.
42. Abe K., Shimizu R., Pan X., Hamada H., Yoshikawa H., Yamamoto M. Stem cells of GATA1-related leukemia undergo pernicious changes after 5-fluorouracil treatment. Exp Hematol 2009, 37:435-445.
43. Kobayashi E., Shimizu R., Kikuchi Y., Takahashi S., Yamamoto M. Loss of the Gata1 gene IE exon leads to variant transcript expression and the production of a GATA1 protein lacking the N-terminal domain. J Biol Chem 2010, 285:773-783.
44. Martelli F., Ghinassi B., Panetta B., et al. Variegation of the phenotype induced by the Gata1low mutation in mice of different genetic backgrounds. Blood 2005, 106:4102-4113.
45. Varricchio L., Mancini A., Migliaccio A.R. Pathological interactions between hemopoietic stem cells and their niche revealed by mouse models of primary myelofibrosis. Expert Review Hematology 2009, 2:315-334.
46. Skoda R.C., Tsai S.F., Orkin S.H., Leder P. Expression of c-MYC under the control of GATA-1 regulatory sequences causes erythroleukemia in transgenic mice. J Exp Med 1995, 181:1603-1613.
47. Montoya M., Schiavoni G., Mattei F., et al. Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood 2002, 99:3263-3271.
48. Follows G.A., Tagoh H., Lefevre P., Hodge D., Morgan G.J., Bonifer C. Epigenetic consequences of AML1-ETO action at the human c-FMS locus. EMBO J 2003, 22:2798-2809.
49. Guyot B., Murai K., Fujiwara Y., et al. Characterization of a megakaryocyte-specific enhancer of the key hemopoietic transcription factor GATA1. J Biol Chem 2006, 281:13733-13742.
50. Menges M., Baumeister T., Rössner S., et al. IL-4 supports the generation of a dendritic cell subset from murine bone marrow with altered endocytosis capacity. J Leukoc Biol 2005, 77:535-543.
51. Shia W.J., Pattenden S.G., Workman J.L. Histone H4 lysine 16 acetylation breaks the genome's silence. Genome Biol 2006, 7. 217-217.
52. Plath K., Fang J., Mlynarczyk-Evans S.K., et al. Role of histone H3 lysine 27 methylation in X inactivation. Science 2003, 300:131-135.
53. Suzuki M., Moriguchi T., Ohneda K., Yamamoto M. Differential contribution of the Gata1 gene hematopoietic enhancer to erythroid differentiation. Mol Cell Biol 2009, 29:1163-1175.
54. Stamatoyannopoulos G., Grosveld F. Hemoglobin switching. Stamatoyannopoulos G and MAJERUS pw, ADS. The molecular basis of blood disease 2001, 135-182. Saunders, Philadelphia.
55. Stamatoyannopoulos G. Control of globin gene expression during development and erythroid differentiation. Exp Hematol 2005, 33:259-271.